Quantcast
Last updated on April 19, 2014 at 18:42 EDT

Latest Endo Health Solutions Inc. Stories

2013-12-16 08:25:33

MALVERN, Pa., Dec. 16, 2013 /PRNewswire/ -- -- Accretive transaction furthers Endo's transformation into leading specialty healthcare company -- Builds on Endo's leadership in pain management through addition of ZECUITY(®) (sumatriptan iontophoretic transdermal system), the first and only FDA approved patch to treat migraine -- Proven Endo branded pharmaceuticals commercial team to execute ZECUITY launch, expected in first half 2014 Endo...

2013-12-11 00:20:47

MALVERN, Pa., Dec. 10, 2013 /PRNewswire/ -- Endo Health Solutions (NASDAQ: ENDP) today announced that Arthur J. Higgins has been appointed to its Board of Directors, effective immediately. Endo also announced that Joseph C. Scodari, 60, will retire as a director, effective December 31, 2013. Recognized for his strategic capabilities, Mr. Higgins has over 30 years of domestic and international pharmaceutical industry experience. He is currently a Senior Advisor to Blackstone...

2013-11-27 20:22:20

MALVERN, Pa., Nov. 27, 2013 /PRNewswire/ -- Endo Health Solutions (Nasdaq: ENDP) ("Endo") today announced that, as reported by the tabulation agent, the requisite holders of its senior notes listed below (collectively the "Notes") had consented to the proposed amendments to the indentures governing the Notes (the "Proposed Amendments"), upon the terms and subject to the conditions set forth in the Consent Solicitation Statement, dated November 19, 2013 (the "Statement")....

2013-11-20 00:21:01

MALVERN, Pa., Nov. 19, 2013 /PRNewswire/ -- Endo Health Solutions (Nasdaq: ENDP) ("Endo") today announced that it has commenced consent solicitations with respect to proposed amendments to the indentures governing its senior notes listed below (collectively the "Notes"), upon the terms and subject to the conditions set forth in the Consent Solicitation Statement, dated November 19, 2013 (the "Statement"). Series of Notes CUSIP Outstanding Principal Amount...

2013-11-12 16:26:57

BUNAVAIL NDA Filed; PDUFA date June 7, 2014 RALEIGH, N.C., Nov. 12, 2013 /PRNewswire/ -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI) announced that it has filed its Quarterly Report on Form 10-Q for the quarter ended September 30, 2013, with the U.S. Securities and Exchange Commission and, in connection therewith, is providing a review of BDSI's recent achievements and an update on business operations and upcoming milestones for 2013 and 2014. (Logo:...

2013-11-11 16:23:43

MALVERN, Pa., Nov. 11, 2013 /PRNewswire/ -- Endo Health Solutions (Nasdaq: ENDP) today announced that Rajiv De Silva, President and CEO, will present a corporate overview at the 2013 Credit Suisse Healthcare Conference on Tuesday, November 12, 2013 at 2:30 p.m. Mountain Standard Time. A live webcast and audio archive of the presentation will be available on the company's website at www.endo.com. Click on Investor Relations, and then the link to the Event and Presentation....

2013-11-08 08:25:10

NEW YORK, November 8, 2013 /PRNewswire/ -- Editor Note: For more information about this release, please scroll to bottom. Today, Analysts' Corner announced new research reports highlighting Endo Health Solutions Inc. (NASDAQ: ENDP), Bristol-Myers Squibb Co. (NYSE: BMY), Express Scripts Holding Company (NASDAQ: ESRX), AbbVie Inc. (NYSE: ABBV), and Incyte Corporation (NASDAQ: INCY). Today's readers may access these reports free of charge - including full price targets,...

2013-11-05 08:33:20

MALVERN, Pa. and MONTREAL, Nov. 5, 2013 /PRNewswire/ -- -- Accelerates Endo's transformation to leading global specialty healthcare company and creates platform for future growth -- Paladin Labs' proven Canadian franchise, robust near-term pipeline and emerging market business complement Endo's U.S. strengths -- Combined company expects to grow presence in North America and internationally -- Stock and cash transaction values Paladin Labs at...

2013-10-29 12:28:55

MALVERN, Pa., Oct. 29, 2013 /PRNewswire/ -- Endo Health Solutions (Nasdaq: ENDP) will announce its third quarter 2013 financial results before the open of the U.S. financial markets on November 7, 2013 and members of its senior management team will host a conference call and webcast at 8:00 a.m. ET that day to discuss these results. Investors and other interested parties may call 866-515-2911 (domestic) or 617-399-5125 (international) and enter passcode 70911744. Please dial in...

2013-09-17 08:31:42

Editor Note: For more information about this release, please scroll to bottom. NEW YORK, September 17, 2013 /PRNewswire/ -- Today, Investors' Reports announced new research reports highlighting Novartis AG (NYSE: NVS), Endo Health Solutions Inc. (NASDAQ: ENDP), The Medicines Company (NASDAQ: MDCO), United Therapeutics Corporation (NASDAQ: UTHR), and Forest Laboratories, Inc. (NYSE: FRX). Today's readers may access these reports free of charge - including full price targets,...